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httpense.Abstract Aim of this study: The aim of this study was to assess the rule of imaging in the superior
orbital ﬁssure syndrome (SOFS) and to identify the rule of the radiologist in guidance of the man-
agement.
Material and methods: This study was conducted on 7 patients with clinical diagnosis of SOFS.
Contrast enhanced MRI was used in examination of all patients. With exception of metastatic
lesions, follow up MRI study was performed to all lesions. Final diagnosis was reached either by
dramatic response to cortico-steroid therapy, tissue biopsy or by correlation with clinical and other
imaging data.
Results: In all patients enhancing abnormal T1 and T2 intermediate intensities are seen localized to
the anatomical site of the superior orbital ﬁssure (SOF). Four patients presented with sheet like
enhancement casting the SOF. Nodular enhancement is noted along the medial aspect of the
SOF in one case. Two patients presented with sizable destructive space occupying lesions at SOF.
Conclusion: In management of SOFS, if there is a dramatic clinical and radiological response to
corticosteroid therapy, we recommend MRI follow-up study after 6 week interval. As the symptoms
were resolving, the potential risks associated with tissue biopsy from that area will be unacceptable.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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The term superior orbital ﬁssure syndrome (SOFS) or Rochon–
Duvigneaud syndrome is applied to lesions located immediately
anterior to the orbital apex, including the structures exiting the
annulus of Zinn and often those external to the annulus. Multi-
ple cranial nerve palsies may be seen including oculomotor
nerve (III), trochlear nerve (IV), abducens nerve (VI) and
ophthalmic branch of the trigeminal nerve (V1) in the absence
of optic nerve pathology (1).Production and hosting by Elsevier B.V.
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the same cranial nerves palsies in association with optic nerve
dysfunction. The cavernous sinus syndrome (CSS) includes the
features of OAS with added involvement of the maxillary
branch of the trigeminal nerve (V2) and oculosympathetic ﬁ-
bers (2). Patients who have features of SOFS may subsequently
develop OAS and CSS (3).
The etiological list is long including inﬂammatory as the
Tolosa–Hunt syndrome, infectious, neoplastic, iatrogenic/
traumatic, or vascular processes (4–10). Neoplastic etiologies
include head and neck tumors, neural tumors, metastatic le-
sions, hematologic malignancies as lymphoma as well as peri-
neural invasion of cutaneous malignancy (11,12).
Periorbital or facial pain reﬂects involvement of the oph-
thalmic (V1) or maxillary (V2) branch of the trigeminal nerve.
THS is an idiopathic inﬂammatory syndrome involving
painful ophthalmoplegia resulting from granulomatous
inﬂammation within the cavernous sinus or orbital apex
(13,14). It typically shows an intermediate signal on MR imag-
ing, enhancing with contrast, typically reduces in size with cor-
ticosteroid therapy on follow-up MRI scan (15).
In 2004, the International Headache Society deﬁned the
diagnostic criteria of THS to include episodes of unilateral
orbital pain persisting for weeks if untreated; associated paral-Table 1 Clinical and MRI features of the patients.
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1 48Y M Episodes of
UPOP Six UCN
Enhan
sheets
to the
2 41Y F Episodes of
UPOP Fourth
UCN Six UCN
Destru
bony l
3 52Y F Episodes of
UPOP Third
UCN Fourth
UCN
Enhan
sheets
to the
4 57Y M Episodes of
UPOP Third
UCN Six UCN
Enhan
sheets
to the
5 63Y M Episodes of
UPOP Six UCN
Enhan
sheets
nodula
SOF
6 60Y F Episodes of
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UPOP=Unilateral peri-orbital pain.
UCN=Unilateral cranial neuropathy.
THS = Tolosa–Hunt syndrome.
Mets =Metastatic lesions.
NHL=Non Hodgkin’s lymphoma.
SOF= Superior orbital ﬁssure.
+=mild, ++=moderate, +++= severe.ysis of one or more of the third, fourth, or sixth cranial nerves;
and/or demonstration of a granuloma by MRI or biopsy (16).
Cranial nerve paresis in THS typically coincides with the onset
of pain or follows it within a period of as long as 2 weeks, and
pain or paresis resolves within 72 h after adequate corticoste-
roid therapy. THS may have a relapsing and remitting course;
however, residual neurologic deﬁcits may persist after remis-
sion (1,17).
Ideally, a biopsy of the enhancing lesion would have helped
to further establish the diagnosis (18). Contrast enhanced fat
suppression sequence MRI brain and orbit is the ideal radio-
logical modality used in these circumstances. CT brain and or-
bit is used in the presence of history of trauma or
contraindications to MRI. If a vascular lesion of the cavernous
sinus is suspected MRA and/or CTA of the cerebral angiogra-
phy may be indicated (19,20).
The primary management options include observation, an
empiric trial of corticosteroids, and biopsy. If symptoms pro-
gresses, repeat neuro-imaging and biopsy are then pursued
(21). Radio and chemotherapy have provided clinical beneﬁt
in a limited number of patients with THS (22–24).
The aim of this study was to assess the rule of imaging in
the superior orbital ﬁssure syndrome (SOFS) and to identify
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Fig. 1 Thirty six year old male patient presented with left sided supra-orbital pain. (A and B) Axial and coronal T2 showed sheet like
intermediate signals along the anatomical site of the left SOF. (C and D) Axial T1 pre and post IV contrast administration scans
respectively showed enhancing signals lateral to the left anterior clinoid process separating the optic foremen medially from the SOF
laterally. (E) Post contrast coronal T1 scan with fat suppression showed the enhancing lesion at its precise location at the left SOF. (F) The
same sequence in (E) was done after 6 weeks of corticosteroid therapy showed a reduction in the size of enhancement. The diagnosis of the
Tolosa–Hunt syndrome was established.
Superior orbital ﬁssure syndrome and its mimics: What the radiologist should know? 591
592 S.A. Shama, U. Gheida2. Materials and methods
This study was conducted on 7 patients with clinical diagnosis
of superior orbital ﬁssure syndrome referred to neuro-orbital
MRI imaging for assessment. It was a mixed retrospective
and prospective study for 18 months.
All patients presented with episodes of unilateral periorbital
pain with associated different combinations of epsilateral
third, fourth and six cranial neuropathy (Table 1). As MRI
is the modality of choice in the assessment of cranial neurop-
athy, it is used in examination of all patients. Features of the
SOFS were reviewed and correlation with clinical data and
therapeutic trials was done. Follow up MRI study was
performed after 6 weeks in all patients except in those patients
with metastatic disease.Fig. 2 (A) Axial T2WI scan with fat suppression (STIR). (B) Axia
contrast coronal T1WI fat suppression scan. The arrows, (A–D) sho
lesion located along the medial aspect of the right SOF extending towar
III, IV and VI cranial neuropathy together with right sided periorbital
corticosteroid therapy. Biopsy was taken. Non Hodgkin’s, lymphoma
The patient received chemotherapy.MR imaging of the orbit was performed using a 1.5 Tesla
magnet (Signa, General Electric Medical Systems, Milwaukee,
WI, USA) using 8-channel head coil. Our standard orbit MRI
protocol includes high-resolution orbit sequences include fast
spin-echo axial T2 fat-suppression (STIR), unenhanced T1,
contrast-enhanced T1, T1 fat-suppressed contrast-enhanced,
coronal T2, T1 fat-suppressed contrast-enhanced, and oblique
para-sagittal T1 fat-suppressed contrast-enhanced. We use
2-mm slice thickness and 0.5-mm interslice gap. Whole-brain
protocol includes sagittal T1WI, FLAIR, axial T2, FLAIR,
and T1 contrast-enhanced sequences. A standard dose of
0.1 mmol/kg of gadodiamide IV contrast material (Omniscan,
GE Healthcare) was given to all patients.
Final diagnosis was reached either by dramatic response to
cortico-steroid therapy in THS, tissue biopsy in cases orl T1WI. (C) Post contrast administration axial T1WI. (D) Post
wed T1 and T2 intermediate intense enhancing small tumifactive
d the right cavernous sinus. This patient presented with right sided
and facial pain (V1 and V2 neuropathy). Mild relief occurred after
was diagnosed. There was no other enlarged nodal mass identiﬁed.
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data in metastatic diseases.
3. Results
This study was conducted on 7 patients with clinical manifesta-
tions of superior orbital ﬁssure syndrome. They were four
females and threemales and their age ranged from41 to 63 years.
They presented with episodes of unilateral peri-orbital pain.
Associated epsilateral six, third and fourth cranial neuropathy
was clinically evident in six, four and three cases respectively.
In all patients enhancing abnormal T1 and T2 intermediate
intensities are seen localized to the anatomical site of the supe-
rior orbital ﬁssure (SOF). These signals are most appreciated
in the contrast enhanced coronal T1 weighted sequence with
fat suppression. Four patients presented with sheet like
enhancement casting the SOF. Nodular enhancement is noted
along the medial aspect of the SOF in one case. Two patients
presented with sizable destructive space occupying lesions at
the SOF showing bone destruction, metastatic tumors were
diagnosed from known breast primary malignancies.
With exception of metastatic lesions, all patients (n= 5) re-
ceived corticosteroid therapy and all of them showed a degree
of improvement of their complaints.
In three cases the peri-orbital pain totally disappeared, fol-
low up MRI study was performed 6 weeks later revealed signif-
icant reduction in the size and extent of enhancing sheets
casting the SOF. The diagnosis of the Tolosa–Hunt syndrome
was established (Fig. 1).
Non Hodgkin’s lymphoma was diagnosed in two patients.
It was diagnosed in one patient during screening for lymphad-
enopathy. Tissue biopsy (from the lesion involving the SOF)
was performed in the other patient, who showed only mild re-
sponse to corticosteroid therapy. The latter patient presented
with focal enhancement along the medial aspect of the SOF
that was pathologically proved to be non Hodgkin’s lym-
phoma (Fig. 2).4. Discussion
The cranial nerve involvement deﬁnes the proper nomencla-
ture of the syndromes involving this region at or around the
orbital apex. Shortening of the long list of the differential diag-
nosis is the main radiological goal. In our study three different
pathological etiological entities for SOFS were diagnosed. Tol-
osa–Hunt syndrome was diagnosed in three cases. Non Hodg-
kin’s lymphoma and metastatic lesions were diagnosed in two
cases each.
In a retrospective review of 151 lesions causing a CSS, tu-
mors were the most frequent cause (45 patients, 30%). When
surgical causes were included with trauma, an iatrogenic/trau-
matic etiology (53 patients, 35%) was the most common cause.
Self-limited inﬂammation was the third most frequent cause
(34 patients, 23%) (11).
The abducent nerve palsy was the most commonly encoun-
tered cranial neuropathy in this study followed by oculomotor
then trochlear nerves.
Lin CC and his co-worker reported a correlation between
the initial number of cranial nerves involved and the likely
hood of having a CSS. In their retrospective study of 68 pa-tients with cranial neuropathies, CSS was found in 7 of 34 pa-
tients (18%) who presented with a cranial mononeuropathy
and in 7 of 9 patients (78%) who presented with involvement
of four cranial nerves. The oculomotor and abducens nerves
were the most frequently involved cranial nerves, followed
by the trochlear nerve (25).
Forderreuther S and his coworkers have suggested that
other causative conditions should be excluded using blood
and cerebrospinal ﬂuid examination and possible biopsy if po-
sitive ﬁndings are seen on MRI or CT. They recommend that
follow-up examinations must then be performed for at least
2 years before the diagnosis of THS is made (26).
We agree with Yousem DM and his coworkers that neuro-
imaging may not be speciﬁc for THS, because meningioma,
lymphoma, and sarcoidosis may have identical signal intensi-
ties on T1 and T2 weighted MRI (27).
In the presence of known primary malignancy, enlarged
lymphadenopathy and other destructive bony lesion, the possi-
bility of neoplastic etiology could be suggested. Otherwise, dis-
tinction between inﬂammation and neoplasia may be difﬁcult,
and all may respond initially to corticosteroids. Judicious use
of corticosteroids is recommended, because the presence of
an occult infection, especially fungal disease, may result in se-
vere morbidity or mortality.
We also agree with Shahrizaila N and his co-workers, as the
symptoms in our patient were resolving spontaneously, the po-
tential risks associated with a neurosurgical biopsy of this area
in question were unacceptable (15).
This study was limited by small number of the studied
cases. The relatively small size of these lesions and the proxim-
ity to bony structures may make application of Diffusion
weighted images (DWI) difﬁcult. Building radiological knowl-
edge and awareness of these lesions will help in future radio-
logical assessment of SOFS.
5. Conclusion
Accurate neuro-orbital imaging using contrast enhanced coro-
nal T1 weighted sequence with fat suppression is recommended
in the assessment of patients presented with peri-orbital pain.
Patients with the SOF syndrome mostly showed degree of
clinical and radiological response to corticosteroid therapy.
If there is a dramatic response, we recommend MRI follow-
up study after a 6 week interval. As the symptoms were resolv-
ing, the potential risks associated with tissue biopsy from that
area will be unacceptable. Good screening especially for lym-
phadenopathy and other malignancies before proceeding to
tissue biopsy is recommended especially in cases that showed
mild response to corticosteroid therapy or those showing
enhancing nodular pattern at SOF.
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